ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exendin-4 alleviates myocardial ischemia reperfusion injury by enhancing autophagy through promoting nuclear translocation of TFEB

He, Weibin; Tong, Guang; Fan, Hualin; Zhen, Cien; Zeng, Lin; Xue, Ling; Chen, Jiyan; Sun, Zhongchan*; He, Pengcheng*广东省人民医院; 广东省心血管病研究所; 南方医科大学
Experimental Cell Research2023-2-15DOI: 10.1016/j.yexcr.2023.113469
3被引6阅读
引用收藏
分享

摘要

Ischemia-reperfusion (I/R) injury (IRI) is a common clinical consequence of myocardial infarction. Exendin-4 is a glucagon-like peptide-1 (GLP-1) analog that has been demonstrated to alleviate myocardial IRI. Autophagy, a lysosomal pathway balancing cell survival and cell death, is engaged in myocardial IRI. However, whether exendin-4 exerts a protective effect on myocardial IRI by modulating autophagy remains elusive. Herein, we investigated the effect of exendin-4 on autophagic flux and explored the underlying molecular mechanisms. Our data revealed that the autophagic flux was blocked in the human ventricular cardiomyocyte cell lines (AC16) subjected to oxygen glucose deprivation/reoxygenation (OGD/R) in vitro. Exendin-4 pre-treatment markedly restored the blocked autophagic flux induced by OGD/R through promoting nuclear translocation of TFEB and transcription of genes involving autophagy initiation, the effect of which was reversed by TFEB knockdown. The restoration of autophagic flux contributed to multiple beneficial effects of exendin-4 in cardiomyocytes, including reduction of oxidative stress, preservation of mitochondrial network as well as inhibition of cyto-chrome c leakage from mitochondrial permeability transition pore (MPTP) and the resulting apoptosis. More-over, the administration of exendin-4 reduced infarct size and preserved cardiac function through its anti-apoptosis and antioxidative effects in vivo. These results shed some light on understanding the novel mecha-nism of exendin-4 as a protective agent against myocardial IRI.

学科与关键词

关键词
Exendin-4Ischemia reperfusion injuryAutophagyTFEB
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Experimental Cell Research
发表日期
2023-02-15
卷期
第 423 卷, 第 2 期
页码
113469
DOI
10.1016/j.yexcr.2023.113469
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Guangdong Provincial People?s Hospital Cardiovascular Research Fund [2020XXG004]; National Natu- ral Science Foundation of China [82170461]; Natural Science Founda- tion of Guangdong Province [2021A1515011121]; Natural Science Foundation of Guangdong Provincial People?s Hospital [8207020425, 8217020758]

作者

  • H

    He, Weibin (第一作者)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • T

    Tong, Guang

    guangdong prov peoples hosp · southern med univ

查看全部 9 位作者收起作者
  • F

    Fan, Hualin

  • Z

    Zhen, Cien

  • Z

    Zeng, Lin

    guangdong prov peoples hosp · southern med univ

  • X

    Xue, Ling

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Jiyan

    guangdong prov peoples hosp · southern med univ

  • S

    Sun, Zhongchan (通讯)

    guangdong prov peoples hosp · southern med univ

  • H

    He, Pengcheng (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417